|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zuo T, Zeng H, Zhang S
and He J: National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 28:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma C, Eltawil KM, Renfrew PD, Walsh MJ
and Molinari M: Advances in diagnosis, treatment and palliation of
pancreatic carcinoma: 1990–2010. World J Gastroenterol. 17:867–897.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perkel JM: Visiting ‘noncodarnia’.
Biotechniques. 54(301): 303–304. 2013.
|
|
6
|
Wang K, Liu F, Zhou LY, Long B, Yuan SM,
Wang Y, Liu CY, Sun T, Zhang XJ and Li PF: The long noncoding RNA
CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res.
114:1377–1388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi K, Yan I, Haga H and Patel T:
Long noncoding RNA in liver diseases. Hepatology. 60:744–753. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng Y, Jutooru I, Chadalapaka G, Corton
JC and Safe S: The long non-coding RNA HOTTIP enhances pancreatic
cancer cell proliferation, survival and migration. Oncotarget.
6:10840–10852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Son J, Lyssiotis CA, Ying H, Wang X, Hua
S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, et
al: Glutamine supports pancreatic cancer growth through a
KRAS-regulated metabolic pathway. Nature. 496:101–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li F, Cao L, Hang D, Wang F and Wang Q:
Long non-coding RNA HOTTIP is up-regulated and associated with poor
prognosis in patients with osteosarcoma. Int J Clin Exp Pathol.
8:11414–11420. 2015.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye H, Liu K and Qian K: Overexpression of
long noncoding RNA HOTTIP promotes tumor invasion and predicts poor
prognosis in gastric cancer. Onco Targets Ther. 9:2081–2088.
2016.PubMed/NCBI
|
|
15
|
Tsang FHC, Au SLK, Wei L, Fan DN, Lee JM,
Wong CC, Ng IO and Wong CM: Long non-coding RNA HOTTIP is
frequently up-regulated in hepatocellular carcinoma and is targeted
by tumour suppressive miR-125b. Liver Int. 35:1597–1606. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quagliata L, Matter MS, Piscuoglio S,
Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z,
Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is
associated with disease progression and predicts outcome in
hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H, Cilz NI, Yang C, Hu B, Dong H and
Lei S: Depression of neuronal excitability and epileptic activities
by group II metabotropic glutamate receptors in the medial
entorhinal cortex. Hippocampus. 25:1299–1313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu LJ, Wall BA, Wangari-Talbot J and Chen
S: Metabotropic glutamate receptors in cancer. Neuropharmacology.
115:193–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Speyer CL, Hachem AH, Assi AA, Johnson JS,
DeVries JA and Gorski DH: Metabotropic glutamate receptor-1 as a
novel target for the antiangiogenic treatment of breast cancer.
PLoS One. 9:e888302014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Speyer CL, Smith JS, Banda M, DeVries JA,
Mekani T and Gorski DH: Metabotropic glutamate receptor-1: A
potential therapeutic target for the treatment of breast cancer.
Breast Cancer Res Treat. 132:565–573. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H J, Li X, Pang H, Pan JJ, Xie XJ and
Chen W: Long non-coding RNA UCA1 promotes glutamine metabolism by
targeting miR-16 in human bladder cancer. Jpn J Clin Oncol.
45:1055–1063. 2015. View Article : Google Scholar : PubMed/NCBI
|
